Updated Date: Tue, 06 Aug 2024 00:00:00 EDT
Vous n'êtes pas connecté
DelveInsight’s, “Melanoma Pipeline Insight 2024” report provides comprehensive insights about 150+ companies and 170+ pipeline drugs in Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also
Updated Date: Tue, 06 Aug 2024 00:00:00 EDT
Updated Date: Fri, 16 Aug 2024 00:00:00 EDT
Adenoid Cystic Carcinoma Market According to DelveInsight, the dynamics of the Adenoid Cystic Carcinoma market are expected to evolve in the coming...
Positive Phase 2a Fibromyalgia Results Deliver Pain Reduction in 100% of Patients, Strengthening IP Position and Clinical Trial Strategy Tryptamine...
Ionis (IONS) enjoys a diverse revenue stream, including numerous sources of collaborative and R&D revenues. These funds enable it to invest in the...
Epstein Barr Virus (EBV) Market In 2021, the Epstein-Barr Virus market across the seven major markets was valued at approximately USD 1.5 billion....
Beam Therapeutics (BEAM) reports mixed second-quarter results. The company remains focused on pipeline development.
Updated Date: Thu, 08 Aug 2024 00:00:00 EDT